What is a stock summary page? Click here for an overview.
Business Description
MediClin AG
ISIN : DE0006595101
Compare
Compare
Traded in other countries / regions
MED.Germany0NDG.UK IPO Date
2000-12-06Description
MediClin AG is a company engaged in operating hospitals. The operating segments of the group are Post-acute, Acute, and Other activities. The company generates the majority of its revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.29 | |||||
| Equity-to-Asset | 0.24 | |||||
| Debt-to-Equity | 2.25 | |||||
| Debt-to-EBITDA | 4.55 | |||||
| Interest Coverage | 0.69 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.19 | |||||
| Beneish M-Score | -3.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.4 | |||||
| 3-Year EBITDA Growth Rate | 9.3 | |||||
| 3-Year EPS without NRI Growth Rate | -6.6 | |||||
| 3-Year FCF Growth Rate | -24.2 | |||||
| 3-Year Book Growth Rate | 3.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1.86 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.02 | |||||
| 9-Day RSI | 48.05 | |||||
| 14-Day RSI | 51.71 | |||||
| 3-1 Month Momentum % | 21.14 | |||||
| 6-1 Month Momentum % | 26.27 | |||||
| 12-1 Month Momentum % | 24.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 0.76 | |||||
| Days Inventory | 21.66 | |||||
| Days Sales Outstanding | 46.83 | |||||
| Days Payable | 32.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 12.85 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.76 | |||||
| Operating Margin % | 2.25 | |||||
| Net Margin % | -1.51 | |||||
| FCF Margin % | 6.05 | |||||
| ROE % | -5.42 | |||||
| ROA % | -1.24 | |||||
| ROIC % | 7.22 | |||||
| 3-Year ROIIC % | -12.43 | |||||
| ROC (Joel Greenblatt) % | 3.96 | |||||
| ROCE % | 2.86 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 7.44 | |||||
| Shiller PE Ratio | 18.93 | |||||
| Price-to-Owner-Earnings | 4.36 | |||||
| PS Ratio | 0.19 | |||||
| PB Ratio | 0.64 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| Price-to-Free-Cash-Flow | 3.02 | |||||
| Price-to-Operating-Cash-Flow | 1.55 | |||||
| EV-to-EBIT | 23.21 | |||||
| EV-to-EBITDA | 4.54 | |||||
| EV-to-Revenue | 0.64 | |||||
| EV-to-FCF | 10.58 | |||||
| Price-to-GF-Value | 0.91 | |||||
| Price-to-Projected-FCF | 0.22 | |||||
| Price-to-DCF (FCF Based) | 0.22 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Earnings Yield (Greenblatt) % | 4.31 | |||||
| FCF Yield % | 32.52 | |||||
| Forward Rate of Return (Yacktman) % | 41.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MediClin AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 741.184 | ||
| EPS (TTM) (€) | -0.24 | ||
| Beta | 0.49 | ||
| 3-Year Sharpe Ratio | -0.22 | ||
| 3-Year Sortino Ratio | -0.34 | ||
| Volatility % | 34.52 | ||
| 14-Day RSI | 51.71 | ||
| 14-Day ATR (€) | 0.048893 | ||
| 20-Day SMA (€) | 2.93 | ||
| 12-1 Month Momentum % | 24.17 | ||
| 52-Week Range (€) | 2.28 - 3.1 | ||
| Shares Outstanding (Mil) | 47.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MediClin AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MediClin AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
MediClin AG Frequently Asked Questions
What is MediClin AG(XTER:MED)'s stock price today?
The current price of XTER:MED is €2.90. The 52 week high of XTER:MED is €3.10 and 52 week low is €2.28.
When is next earnings date of MediClin AG(XTER:MED)?
The next earnings date of MediClin AG(XTER:MED) is .
Does MediClin AG(XTER:MED) pay dividends? If so, how much?
MediClin AG(XTER:MED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers